HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C.

AbstractBACKGROUND AND AIM:
The possible involvement of oxidative stress in hepatitis C virus (HCV)-induced liver damage and hepatocarcinogenesis has been reported. We have recently developed a novel method to measure total hydroxyoctadecadienoic acid (tHODE) and have proposed its usefulness as a biomarker for lipid peroxidation. The present study was undertaken to evaluate oxidative stress in HCV-infected liver diseases by several potential oxidative stress markers including tHODE and further to validate the biomarkers for evaluating the efficacy of iron reduction therapy.
METHODS:
Total hydroxyoctadecadienoic acid, total 8-iso-prostagrandin F(2alpha) (t8-iso-PGF(2alpha)), selenoprotein P and other antioxidant compounds were measured in the plasma and erythrocytes obtained from 42 healthy controls and 78 HCV patients. Plasma levels of biomarkers and antioxidants were also assessed during the iron reduction therapy for 16 weeks in 12 HCV patients.
RESULTS:
The concentrations of tHODE in the plasma and erythrocytes and t8-iso-PGF(2alpha) in the plasma of chronic HCV-infected patients were significantly higher than those of healthy controls. Plasma levels of vitamin E and vitamin C of HCV-infected patients were lower than those of the controls. Furthermore, the plasma tHODE significantly correlated with serum aminotransferases and type IV collagen-7S domain in chronic HCV-infected patients. During the iron reduction therapy, the plasma levels of tHODE but not t8-iso-PGF(2alpha) decreased and inversely its stereo-isomer ratio (ZE/EE) increased in parallel with the decreases of serum alanine aminotransferase, ferritin and alpha-fetoprotein.
CONCLUSION:
The levels of tHODE in chronic HCV-infected patients can be a useful biomarker for the evaluation of oxidative stress in chronic hepatitis C.
AuthorsYasukazu Yoshida, Yasuharu Imai, Yoshiyuki Sawai, Yoshiro Saito, Jiaofei Cao, Kazuto Fukuda, Etsuo Niki
JournalJournal of gastroenterology and hepatology (J Gastroenterol Hepatol) Vol. 25 Issue 1 Pg. 107-15 (Jan 2010) ISSN: 1440-1746 [Electronic] Australia
PMID19780883 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
Chemical References
  • Antioxidants
  • Biomarkers
  • Fatty Acids, Unsaturated
  • Hemoglobins
  • RNA, Viral
  • hydroxyoctadecadienoic acid
  • 8-epi-prostaglandin F2alpha
  • Ferritins
  • Dinoprost
Topics
  • Aged
  • Antioxidants (metabolism)
  • Biomarkers (blood)
  • Dinoprost (analogs & derivatives, blood)
  • Fatty Acids, Unsaturated (blood)
  • Female
  • Ferritins (blood)
  • Hemoglobins (metabolism)
  • Hepacivirus (genetics)
  • Hepatitis C (blood, diagnosis, therapy)
  • Humans
  • Liver (metabolism, virology)
  • Liver Cirrhosis (blood, therapy, virology)
  • Male
  • Middle Aged
  • Oxidative Stress (drug effects)
  • Phlebotomy
  • Predictive Value of Tests
  • Prospective Studies
  • RNA, Viral (blood)
  • Reproducibility of Results
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: